Jasper Net Income from 2010 to 2025

JSPRW Stock  USD 0.14  0.01  7.69%   
Jasper Therapeutics Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss is likely to outpace its year average in 2025. During the period from 2010 to 2025, Jasper Therapeutics Net Loss regression line of quarterly data had mean square error of 223.4 T and geometric mean of  11,115,953. View All Fundamentals
 
Net Loss  
First Reported
2020-03-31
Previous Quarter
-18.6 M
Current Value
46.9 M
Quarterly Volatility
14.4 M
 
Covid
Check Jasper Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jasper Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Selling General Administrative of 13.1 M or Other Operating Expenses of 40 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.31. Jasper financial statements analysis is a perfect complement when working with Jasper Therapeutics Valuation or Volatility modules.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Latest Jasper Therapeutics' Net Income Growth Pattern

Below is the plot of the Net Income of Jasper Therapeutics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Jasper Therapeutics financial statement analysis. It represents the amount of money remaining after all of Jasper Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Jasper Therapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jasper Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (71.27 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Jasper Net Income Regression Statistics

Arithmetic Mean(20,821,034)
Geometric Mean11,115,953
Coefficient Of Variation(119.55)
Mean Deviation19,792,543
Median(4,987,000)
Standard Deviation24,891,822
Sample Variance619.6T
Range66.3M
R-Value(0.81)
Mean Square Error223.4T
R-Squared0.66
Significance0.0001
Slope(4,258,492)
Total Sum of Squares9294T

Jasper Net Income History

2025-67.7 M
2024-71.3 M
2023-64.5 M
2022-24.2 M
2021-24 M
2020-31.7 M

Other Fundumenentals of Jasper Therapeutics

Jasper Therapeutics Net Income component correlations

About Jasper Therapeutics Financial Statements

Jasper Therapeutics investors use historical fundamental indicators, such as Jasper Therapeutics' Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jasper Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-71.3 M-67.7 M
Net Loss-71.3 M-67.7 M
Net Loss-5.8 M-6.1 M
Net Loss(5.56)(5.84)
Net Income Per E B T 0.88  0.64 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.